[Beta-mimetic tocolysis: maternal and fetal side-effects].

Area of Science:

• Obstetrics and Gynecology
• Pharmacology
• Maternal-Fetal Medicine

Context:

• Beta-mimetic tocolytics are frequently used to manage preterm labor.
• Maternal and fetal well-being are paramount during tocolytic therapy.
• Understanding the side effect profile of tocolytics is essential for clinical practice.

Purpose:

• To review and synthesize the existing literature on the materno-fetal effects of beta-mimetic tocolytics.
• To identify and characterize the adverse events associated with beta-mimetic tocolytic administration.
• To provide evidence-based recommendations for the safe and effective use of these medications.

Summary:

• Administration of beta-mimetic tocolytics is associated with a range of adverse maternal and fetal effects.
• These effects are predominantly metabolic and cardiocirculatory in nature, and while typically reversible, can lead to serious complications in patients with underlying conditions.
• A critical assessment of the literature supports the continued utility of beta-mimetic tocolytics when their use is clearly indicated and preceded by thorough cardiocirculatory and metabolic assessment.

Impact:

• Highlights the importance of vigilant monitoring for adverse effects during tocolytic therapy.
• Emphasizes the need for individualized risk-benefit assessments before initiating beta-mimetic tocolytics.
• Informs clinical guidelines and practice regarding the judicious use of beta-mimetic agents in obstetric care.